Feeds:
Posts
Comments

Posts Tagged ‘Bayer’

NEW YORK TIMES: A nonprofit group in Washington has filed a lawsuit against Bayer Healthcare charging that the company’s labels and commercials falsely claimed its One A Day multi-vitamins for men may reduce the risk of prostate cancer. READ MORE>

Read Full Post »

NORWAY POST: Alpharadin, a new drug that treats men with hormone-refractory prostate cancer that has spread to the bone, will be developed by a Norwegian cancer therapeutics company and global drugs giant Bayer. READ MORE>

Read Full Post »